The Claim

Neutrophil-derived hypochlorous acid targets epithelial cell plasmalogens to produce 2-chlorofatty aldehydes, as demonstrated in transwell co-culture experiments with activated neutrophils, indicating a mechanism for chlorinated lipid generation during inflammation.

Source: Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
3score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

When certain immune cells get activated, they release a chemical that reacts with fats in nearby tissue cells to create new types of chlorinated fats, which might play a role in inflammation.

See the scientific wording

Neutrophil-derived hypochlorous acid targets epithelial cell plasmalogens to produce 2-chlorofatty aldehydes (2-ClFALD), as shown in transwell co-culture experiments with activated neutrophils, indicating a mechanism for chlorinated lipid generation during inflammation.

What the research says

1 study

  1. Study: Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes

    The study shows exactly what the claim says: white blood cells use a chemical to turn certain fats in lung cells into a different type of chemical, which happens during infections.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.